Drugs / Diclofenac SR
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00762463 Comparator | Jul 2009 → Jun 2010 | ankylosing spondylitis | Viatris Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Diclofenac SR | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00762463 ↗ |
| Known as | diclofenac sustained release | “This Phase 3, double-blind, parallel-group study randomized patients with AS aged ≥18 to 65 years 1:1 to receive celecoxib 200 mg once daily or diclofenac sustained release 75...” PMID 25516774 ↗ Dec 2014 |